Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors
吉西他滨可治疗性地破坏非典型畸胎瘤/横纹肌样瘤中必需的 SIRT1 介导的 p53 抑制
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2024.101700
Dennis S Metselaar, Michaël H Meel, Joshua R Goulding, Aimeé du Chatinier, Leyla Rigamonti, Piotr Waranecki, Neal Geisemeyer, Mark C de Gooijer, Marjolein Breur, Jan Koster, Sophie E M Veldhuijzen van Zanten, Marianna Bugiani, Niels E Franke, Alyssa Reddy, Pieter Wesseling, Gertjan J L Kaspers, Esth
